SEC Form 4 · accession 0001562180-17-002595
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Teresa L. Kline
Director
Period of report
Aug 1, 2017
Accepted (ET)
Aug 3, 2017 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $27.55 | Aug 1, 2017 | A | 13,787 | A | — | Jul 31, 2027 | Common Stock | 13,787 | 13,787 | D |
Explanation of responses
- F1The vesting commencement date of the option is August 1, 2017. 25% of the shares subject to the option shall vest on August 1, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.